An indicator of cancer: downregulation of Monoamine Oxidase-A in multiple organs and species
Autor: | Dorothy Pathak, Leszek A Rybaczyk, Kun Huang, Meredith J. Bashaw |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2008 |
Předmět: |
Serotonin
lcsh:QH426-470 Colorectal cancer lcsh:Biotechnology Down-Regulation Bioinformatics Serotonergic Mice Downregulation and upregulation Species Specificity lcsh:TP248.13-248.65 Neoplasms Genetics medicine Animals Humans Zebrafish Monoamine Oxidase Regulation of gene expression biology Cancer medicine.disease biology.organism_classification Rats Gene Expression Regulation Neoplastic lcsh:Genetics Organ Specificity Gene chip analysis biology.protein Monoamine oxidase A Biotechnology Research Article |
Zdroj: | BMC Genomics BMC Genomics, Vol 9, Iss 1, p 134 (2008) |
ISSN: | 1471-2164 |
Popis: | Background Identifying consistent changes in cellular function that occur in multiple types of cancer could revolutionize the way cancer is treated. Previous work has produced promising results such as the identification of p53. Recently drugs that affect serotonin reuptake were shown to reduce the risk of colon cancer in man. Here, we analyze an ensemble of cancer datasets focusing on genes involved in the serotonergic pathway. Genechip datasets consisting of cancerous tissue from human, mouse, rat, or zebrafish were extracted from the GEO database. We first compared gene expression between cancerous tissues and normal tissues for each type of cancer and then identified changes that were common to a variety of cancer types. Results Our analysis found that significant downregulation of MAO-A, the enzyme that metabolizes serotonin, occurred in multiple tissues from humans, rodents, and fish. MAO-A expression was decreased in 95.4% of human cancer patients and 94.2% of animal cancer cases compared to the non-cancerous controls. Conclusion These are the first findings that identify a single reliable change in so many different cancers. Future studies should investigate links between MAO-A suppression and the development of cancer to determine the extent that MAO-A suppression contributes to increased cancer risk. |
Databáze: | OpenAIRE |
Externí odkaz: |